Mamoru Hashimoto

8PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - proteins and peptides (incl. medical proteomics)Neurology and neuromuscular diseasesFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 28, 2026
Enfortumab vedotin plus pembrolizumab for recurrent metastatic urothelial carcinoma following adjuvant nivolumab.

|Aug 14, 2025
Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer.

Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto

|Apr 24, 2025
Comorbid Diabetes Mellitus Contributes to Residual Overactive Bladder After Transurethral Surgery for Benign Prostatic Hyperplasia.

Koji Miki, Keisuke Kiba, Daisuke Maenosono

|Jan 31, 2025
Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate.

Mitsuhisa Nishimoto, Marco A De Velasco, Yutaka Yamamoto

|Nov 16, 2023
Urinary markers for bladder cancer diagnosis: A review of current status and future challenges.

Eisuke Tomiyama, Kazutoshi Fujita, Mamoru Hashimoto

|May 13, 2023
Molecular Mechanisms of Neurogenic Lower Urinary Tract Dysfunction after Spinal Cord Injury.

Nobutaka Shimizu, Tetsuichi Saito, Naoki Wada

Pageof 2

Frequent Collaborators

3 joint publications

Yutaka Yamamoto

2 joint publications

Nobutaka Shimizu

2 joint publications

Kazuhiro Yoshimura

2 joint publications

Akihide Hirayama